Essay About Financial Analysis And Medical Instrument Manufacturing.Auditor

Paradigm Shift in Primary Care – Defining New Roles in Occupational Therapy
Financial Analysis[pic 1]Name: Medtronic, Inc. (NYSE- MDT)Principal Office: 710 Medtronic Pkwy., N.E. Minneapolis,  MN  55432, (763) 514-4000Website: www.medtronic.comNAICS: 325412: Pharmaceutical Preparation ManufacturingPrimary SIC: 3845- Electromedical and Electrotherapeutic Apparatus ManufacturingSecondary SIC: 339112- Surgical and Medical Instrument Manufacturing.Auditor: PricewaterhouseCoopers LLP, New York, NYPrimary Bank: Wells Fargo Bank, N.A., Minneapolis, MNCompany started: 1949Number of Employees: 45,499Table of Contents:Sl.TopicsPage1General Description of Medtronic Inc.12Challenges 2.a. Medical Device Industry2.b. Medtronic Inc.33Ethical issues54Financial Analysis4.a. Financial Analysis of 10K                                                                          4.b.Cost and expenses analysis 4.c. Financial Ratios6895Industry/Competitor Analysis116Conclusion 137Bibliography14By Geethapriya Setty(100918266)Address: 1300 Hennepin Ave, Apt M101, Minneapolis,  Minnesota-55403Section 1: General Description of Medtronic Inc.Medtronic Inc., a medical technology company, was founded in 1949 by Earl Bakken and Palmer Hermundslie. It was incorporated in 1957 in Minneapolis, Minnesota. They were the first to create a wearable cardiac pacemaker in 1957. They have been able to expand their business from a small repair company, which serviced medical equipment in hospitals, to being able to serve physicians and patients in more than 120 countries worldwide. From then on they focused on cardiac rhythm technology that makes up approximately 52% of their net sales (fiscal year 2012). [1]Along with CRDM, they also have an additional 7 areas they specialize in which are as follows-